Shanghai, China

Tao Jiang

This inventor holds 33 USPTO granted patents and 17 published patent applications and 6 EPO patents, primarily in Biomedical Devices. Top assignees: International Business Machines Corporation, Huawei Technologies Co., Limited, Becton Dickinson and Company Limited. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tao Jiang. Retrieved from https://idiyas.com/inventor/tao-jiang-dr1cc7li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 

% Patents Active = 63.6

 

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 75(Granted Patents)


Location History:

  • Wuhan, CN (2017 - 2019)
  • Hubei, CN (2022)
  • Shanghai, CN (2016 - 2024)

Company Filing History:


Years Active: 2016-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Blood Collection
Catheter System
Voltage Adjustment
Phased Array Antenna
Dielectric Filter
Electric Vehicle
Wireless Authentication
Data Processing
Mobile Device Navigation
Touchscreen Unlocking
Keypad Utilization
Slicing Device
33 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Tao Jiang

Introduction

Tao Jiang, an accomplished inventor located in Shanghai, China, has made significant strides in the field of medical devices and pharmaceuticals. With a remarkable portfolio of 29 patents, Jiang's work focuses on innovations that address critical health care needs. His latest patents reveal a commitment to advancing technology for blood collection and cancer treatment.

Latest Patents

One of Jiang's notable recent inventions is a blood collection device that encompasses a vascular access system designed for efficient blood draw. This system features a housing that includes a distal and proximal end with a uniquely designed slot. The device allows for movement of a cannula hub, enabling enhanced access for blood collection. The innovative design ensures that the cannula's distal tip is properly positioned for use.

Additionally, Jiang has developed a substituted heterocyclic fused cyclic compound, aimed at combating KRAS gene mutations, which are often implicated in various cancers. This compound promises to be a crucial element in the development of new cancer drugs, showcasing Jiang's dedication to impactful pharmaceutical research.

Career Highlights

Throughout his career, Tao Jiang has contributed to influential organizations such as IBM and Huawei Technologies Co., Limited. His work in these prestigious companies has allowed him to refine his expertise in technology and innovation, ultimately leading to the development of his impressive patented technologies.

Collaborations

Jiang has collaborated with notable professionals, including Xian Dong Meng and George James Romano. These partnerships have fostered a creative environment conducive to groundbreaking developments in the healthcare sector.

Conclusion

Tao Jiang's innovative work in blood collection devices and pharmaceutical advancements underscores his vital role as an inventor. With an extensive list of patents and valuable collaborations, Jiang continues to be a significant figure in the realm of healthcare innovation. His contributions not only enhance existing technologies but also pave the way for future breakthroughs in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…